BioCare Looks to Strengthen Specialty Distribution Business After The Vistria Group Acquisition

The Vistria Group, LP (Vistria) recently announced the acquisition of BioCare, Inc. (BioCare), a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy and logistics services.

Founded in 1982, BioCare encompasses BioCareSD, a leading specialty distributor of life-saving therapies, LogiCare3PL, a national provider of time and temperature-sensitive pharmaceutical logistics services, and CanyonCareRX, a full-service specialty pharmacy.

The Vistria Group is a purpose-driven private investment firm focused on investing in middle market companies in the healthcare, education, and financial services sectors.

The company partners with pharmaceutical manufacturers, connecting them to healthcare providers from hospitals, specialty pharmacies, ambulatory infusion centers, physician infusion suites, and other alternate site locations. 

BioCareSD has developed a network which can provide four to six hour delivery anywhere in the country when needed, from a customer’s initial request, to the moment the treatment reaches the patient, with on-demand service and 24/7 support.  

BioCareSD is an Authorized Distributor of Record for all the manufacturers it represents in the following areas:

  • Hematology
  • Immunology
  • Albumin
  • HAE
  • Neurology
  • Specialty Products

BioCareSD also serves as one of the largest distributors of hemophilia therapies in the country and enjoys continued access to a range of new specialty drugs, as a pioneer in the space. In response to demand from its customers, the company has expanded into the non-acute segment and continues to diversify its offerings.


Takeaway: BioCare plans to invest the additional resources from The Vistria Group to better serve its customers and reach more patients who suffer from rare, ultra-rare and orphan diseases